Bristol Myers Squibb names Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer
Princeton: Bristol Myers Squibb has announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after an extraordinary 33-year career at the company.
Gallman, an accomplished leader with extensive experience in pharmaceutical law and compliance, will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. She has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as Executive Vice President, Corporate Affairs.
“Cari brings a unique combination of legal, policy and communications expertise, coupled with an impressive ability to inspire teams, uphold ethical business practices and champion patient voices,” said Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb. “I am confident that under Cari’s leadership, our legal and policy teams are well positioned to advance Bristol Myers Squibb’s efforts to drive and deliver innovation to patients facing serious diseases.”
“It is an honor to have the opportunity to lead the incredible teams that govern and counsel Bristol Myers Squibb in advancing its mission to deliver transformational medicines to more patients,” said Gallman. “I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients.”
On Sandy’s retirement, Boerner said, “Sandy’s resilience, steadfast leadership, and unwavering commitment to patients have left an indelible mark on our company. On behalf of the entire organization, I want to express our deepest gratitude to Sandy for her decades of service and wish her all the best in her well-deserved retirement.”
Prior to her appointment as Bristol Myers Squibb’s Executive Vice President, General Counsel and Chief Policy Officer, Cari Gallman served as Executive Vice President, Corporate Affairs and was responsible for advancing the company strategy through strategic communications, government relations and policy, corporate social responsibility, corporate marketing and brand reputation, and patient advocacy.
Previously, Gallman served as Chief Compliance and Ethics officer, where she championed Bristol Myers Squibb’s culture of integrity, ensuring the company conducted its business in compliance with ethical business practices and laws and regulations in the global markets in which it operates. Gallman joined Bristol Myers Squibb in 2015 and assumed positions of increasing responsibility, including as head of the legal team supporting the Global Oncology Commercialization and Development organizations.
Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in a variety of complex civil, regulatory, and government enforcement matters.
Gallman earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and a JD from Harvard Law School.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.